Recordati Rare Diseases SARL
Recordati Rare Diseases SARL, a prominent player in the pharmaceutical industry, is headquartered in France and operates extensively across Europe and beyond. Founded in 2011, the company has rapidly established itself as a leader in the development and commercialisation of innovative treatments for rare diseases, focusing on areas such as metabolic disorders and genetic conditions. With a commitment to improving patient outcomes, Recordati Rare Diseases offers a range of unique therapies that address unmet medical needs. Their core products are distinguished by their efficacy and safety profiles, setting them apart in a competitive market. The company has achieved significant milestones, including strategic partnerships and a growing portfolio of approved therapies, solidifying its position as a trusted name in rare disease management.
DitchCarbon Score
How does Recordati Rare Diseases SARL's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Recordati Rare Diseases SARL's score of 33 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Recordati Rare Diseases SARL's reported carbon emissions
Recordati Rare Diseases SARL, headquartered in France, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or climate commitments. This lack of information suggests that Recordati Rare Diseases SARL may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the industry increasingly prioritises sustainability and carbon footprint reduction, it will be essential for Recordati Rare Diseases SARL to establish clear climate commitments and measurable targets to align with global climate initiatives.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Recordati Rare Diseases SARL is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
